166 related articles for article (PubMed ID: 16153121)
1. Cleavage of disulfide-linked fetuin-bisphosphonate conjugates with three physiological thiols.
Zhang S; Wright JE; Bansal G; Cho P; Uludag H
Biomacromolecules; 2005; 6(5):2800-8. PubMed ID: 16153121
[TBL] [Abstract][Full Text] [Related]
2. Imparting mineral affinity to proteins with thiol-labile disulfide linkages.
Bansal G; Wright JE; Zhang S; Zernicke RF; Uludag H
J Biomed Mater Res A; 2005 Sep; 74(4):618-28. PubMed ID: 16037953
[TBL] [Abstract][Full Text] [Related]
3. A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages.
Wright JE; Gittens SA; Bansal G; Kitov PI; Sindrey D; Kucharski C; Uludağ H
Biomaterials; 2006 Feb; 27(5):769-84. PubMed ID: 16055182
[TBL] [Abstract][Full Text] [Related]
4. The interaction of cationic polymers and their bisphosphonate derivatives with hydroxyapatite.
Zhang S; Wright JE; Ozber N; Uludağ H
Macromol Biosci; 2007 May; 7(5):656-70. PubMed ID: 17457941
[TBL] [Abstract][Full Text] [Related]
5. Imparting mineral affinity to fetuin by bisphosphonate conjugation: a comparison of three bisphosphonate conjugation schemes.
Gittens SA; Bansal G; Kucharski C; Borden M; Uludag H
Mol Pharm; 2005; 2(5):392-406. PubMed ID: 16196492
[TBL] [Abstract][Full Text] [Related]
6. Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.
Gittens SA; Bagnall K; Matyas JR; Löbenberg R; Uludag H
J Control Release; 2004 Aug; 98(2):255-68. PubMed ID: 15262417
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases.
Wang G; Mostafa NZ; Incani V; Kucharski C; Uludağ H
J Biomed Mater Res A; 2012 Mar; 100(3):684-93. PubMed ID: 22213565
[TBL] [Abstract][Full Text] [Related]
9. Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.
Gittens SA; Kitov PI; Matyas JR; Löbenberg R; Uludağ H
Pharm Res; 2004 Apr; 21(4):608-16. PubMed ID: 15139517
[TBL] [Abstract][Full Text] [Related]
10. Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis.
Doschak MR; Kucharski CM; Wright JE; Zernicke RF; Uludağ H
Mol Pharm; 2009; 6(2):634-40. PubMed ID: 19718808
[TBL] [Abstract][Full Text] [Related]
11. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
[TBL] [Abstract][Full Text] [Related]
12. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
[TBL] [Abstract][Full Text] [Related]
13. New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability.
Arpicco S; Dosio F; Brusa P; Crosasso P; Cattel L
Bioconjug Chem; 1997; 8(3):327-37. PubMed ID: 9177838
[TBL] [Abstract][Full Text] [Related]
14. Thiolytically cleavable dithiobenzyl urethane-linked polymer-protein conjugates as macromolecular prodrugs: reversible PEGylation of proteins.
Zalipsky S; Mullah N; Engbers C; Hutchins MU; Kiwan R
Bioconjug Chem; 2007; 18(6):1869-78. PubMed ID: 17935288
[TBL] [Abstract][Full Text] [Related]
15. Aromatic thiol pKa effects on the folding rate of a disulfide containing protein.
Gough JD; Gargano JM; Donofrio AE; Lees WJ
Biochemistry; 2003 Oct; 42(40):11787-97. PubMed ID: 14529290
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of biological thiols by highly reactive disulfide-S-oxides.
Giles GI; Tasker KM; Jacob C
Gen Physiol Biophys; 2002 Mar; 21(1):65-72. PubMed ID: 12168727
[TBL] [Abstract][Full Text] [Related]
18. Transcellular processing of disulfide- and thioether-linked peroxidase--polylysine conjugates in cultured MDCK epithelial cells.
Wan JS; Persiani S; Shen WC
J Cell Physiol; 1990 Oct; 145(1):9-15. PubMed ID: 2211845
[TBL] [Abstract][Full Text] [Related]
19. Designing proteins for bone targeting.
Gittens SA; Bansal G; Zernicke RF; Uludağ H
Adv Drug Deliv Rev; 2005 May; 57(7):1011-36. PubMed ID: 15876401
[TBL] [Abstract][Full Text] [Related]
20. ortho- and meta-substituted aromatic thiols are efficient redox buffers that increase the folding rate of a disulfide-containing protein.
Gough JD; Barrett EJ; Silva Y; Lees WJ
J Biotechnol; 2006 Aug; 125(1):39-47. PubMed ID: 16616966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
